data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Alternative Investment Platforms
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
Watch
YouTube
Podcasts
Trading School
My Stocks
Tools
Premium
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
Agios Pharmaceuticals
(NASDAQ:AGIO)
$29.45
0.47[1.62%]
At close: Oct 4
$29.45
After Hours: 4:01PM EDT
Day Range29.07 - 30.3152 Wk Range16.75 - 35.12Open / Close29.45 / 29.45Float / Outstanding48.6M / 54.8M
Vol / Avg.581.4K / 740.9KMkt Cap1.6BP/E-50d Avg. Price27.95
Div / Yield-Payout Ratio-Total Float48.6MEPS-1.68

Agios Pharmaceuticals Stock (NASDAQ:AGIO), Quotes and News Summary

Agios Pharmaceuticals Stock (NASDAQ: AGIO)

Day Range29.07 - 30.3152 Wk Range16.75 - 35.12Open / Close29.45 / 29.45Float / Outstanding48.6M / 54.8M
Vol / Avg.581.4K / 740.9KMkt Cap1.6BP/E-50d Avg. Price27.95
Div / Yield-Payout Ratio-Total Float48.6MEPS-1.68
Sector: Health Care.Industry: Biotechnology
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.
Read More

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-02
REV
Q2 2022Est.ActualSurprise
EPS-1.750-1.680 0.0700
REV2.420M5.582M3.162M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Agios Pharmaceuticals Questions & Answers

Q
How do I buy Agios Pharmaceuticals (AGIO) stock?
A

You can purchase shares of Agios Pharmaceuticals (NASDAQ: AGIO) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Agios Pharmaceuticals's (AGIO) competitors?
Q
What is the target price for Agios Pharmaceuticals (AGIO) stock?
A

The latest price target for Agios Pharmaceuticals (NASDAQ: AGIO) was reported by SVB Leerink on Friday, August 5, 2022. The analyst firm set a price target for 37.00 expecting AGIO to rise to within 12 months (a possible 25.64% upside). 14 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Agios Pharmaceuticals (AGIO)?
A

The stock price for Agios Pharmaceuticals (NASDAQ: AGIO) is $29.45 last updated Today at October 4, 2022, 8:00 PM UTC.

Q
Does Agios Pharmaceuticals (AGIO) pay a dividend?
A

There are no upcoming dividends for Agios Pharmaceuticals.

Q
When is Agios Pharmaceuticals (NASDAQ:AGIO) reporting earnings?
A

Agios Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 2, 2022.

Q
Is Agios Pharmaceuticals (AGIO) going to split?
A

There is no upcoming split for Agios Pharmaceuticals.

Q
What sector and industry does Agios Pharmaceuticals (AGIO) operate in?
A

Agios Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.